302 related articles for article (PubMed ID: 24771498)
1. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience.
Ramachandran R; Kumar V; Rathi M; Nada R; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrol Dial Transplant; 2014 Oct; 29(10):1918-24. PubMed ID: 24771498
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure.
Li X; Xu N; Li H; Han F; Wang R; He Q; He X; Chen J
Nephrol Dial Transplant; 2013 Sep; 28(9):2306-12. PubMed ID: 23787554
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of collapsing focal segmental glomerulosclerosis.
Raja R; Nada R; Yadav AK; Kumar A; Goyal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
Ren H; Shen P; Li X; Pan X; Zhang W; Chen N
Am J Nephrol; 2013; 37(1):84-90. PubMed ID: 23343906
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial.
Fan L; Liu Q; Liao Y; Li Z; Ji Y; Yang Z; Chen J; Fu J; Zhang J; Kong Y; Fu P; Lou T; Liu Z; Yu X; Chen W
Int Urol Nephrol; 2013 Apr; 45(2):459-68. PubMed ID: 22684795
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome.
Supavekin S; Surapaitoolkorn W; Kurupong T; Chaiyapak T; Piyaphanee N; Pattaragarn A; Sumboonnanonda A
J Med Assoc Thai; 2013 Jan; 96(1):33-40. PubMed ID: 23720975
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.
Westhoff TH; Schmidt S; Zidek W; Beige J; van der Giet M
Clin Nephrol; 2006 Jun; 65(6):393-400. PubMed ID: 16792133
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
[TBL] [Abstract][Full Text] [Related]
11. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD; MacLeod R; Rigby E; Clark AG
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
13. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
[TBL] [Abstract][Full Text] [Related]
14. Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus.
Bhimma R; Adhikari M; Asharam K; Connolly C
Am J Nephrol; 2006; 26(6):544-51. PubMed ID: 17159342
[TBL] [Abstract][Full Text] [Related]
15. Chlormethine Hydrochloride is Not Inferior to Tacrolimus in Treating Steroid-Resistant Nephrotic Syndrome.
Yang Y; Zhao L; Xiao L; Liang Y; Wang C; Fu X; Zhu X; Yuan S; Zhu J; Zhu X; Liu Y; Li J; Luo J; Liu F; Sun L
Kidney Blood Press Res; 2018; 43(1):68-79. PubMed ID: 29402844
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A; Hari P; Moudgil A; Jordan SC
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
18. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J; Ehrich JH; Querfeld U
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[TBL] [Abstract][Full Text] [Related]
19. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[TBL] [Abstract][Full Text] [Related]
20. Effective therapy of a child case of refractory nephrotic syndrome with tacrolimus.
Tsugawa K; Tanaka H; Nakahata T; Ito E
Tohoku J Exp Med; 2004 Nov; 204(3):237-41. PubMed ID: 15502424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
